ExoDx Prostate Test
Commercial- Indications
- Prostate cancer
Company intelligence / Profile preview
Exosome Diagnostics
Waltham, Massachusetts, USAexosomedx.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Exosome Diagnostics developed the first clinically available urine-based exosomal RNA diagnostic test to help guide prostate biopsy decisions. Their proprietary technology enables noninvasive detection of tumor-derived genetic material from body fluids such as blood or urine. The company’s lead product "ExoDx Prostate IntelliScore" (EPI) helps urologists determine the need for prostate biopsies in men with ambiguous PSA results. Additional pipeline efforts target other hard-to-detect cancers using similar liquid biopsy approaches. The company was acquired by Bio-Techne in August 2018 but continues to operate as a brand within Bio-Techne.
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- Diagnostic test (liquid biopsy)Biomarker detection
- Industry
- Molecular Diagnostics
02
Drug pipeline
1 asset03
Partnerships
Qiagen licensed/distributes some technologies/products globally ("exoEasy")
Beyond the preview
Go deeper on Exosome Diagnostics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Exosome Diagnostics.